agilon health, inc.
Close on Oct 19, 2026
- Market cap
- $1.53B
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 3, 2026, during market hours (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 5, 2026 | During market hours | $1.49B | – | $70.00 |
| Q1 FY2026 Ended Mar 31, 2026 | May 6, 2026 | During market hours | – | – | – |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 25, 2026 | During market hours | $1.57B | $-0.46 | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 4, 2025 | During market hours | $1.44B | $-0.27 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 4, 2025 | During market hours | $1.39B | $-0.25 | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 6, 2025 | During market hours | $1.53B | – | – |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 25, 2025 | During market hours | $1.52B | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 7, 2024 | During market hours | $1.45B | – | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 6, 2024 | During market hours | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 7, 2024 | During market hours | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 27, 2024 | During market hours | – | – | – |
Company guidance
Outlook given with results on Feb 25, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted EBITDAnon-GAAP | Year Ended December 31, 2026 | -$15.00M to $15.00M | New |
| Adjusted EBITDAnon-GAAP | Quarter Ended March 31, 2026 | $35.00M to $45.00M | New |
| Medicare Advantage Members | Year Ended December 31, 2026 | 425,000 to 435,000 | New |
| ACO Model Members | Year Ended December 31, 2026 | 100,000 to 105,000 | Lowered |
| Total Members Live on Platform | Year Ended December 31, 2026 | 525,000 to 540,000 | Raised |
| Avg. Medicare Advantage Members | Year Ended December 31, 2026 | 427,000 to 437,000 | Lowered |
| Geography Entry Costs | Year Ended December 31, 2026 | $15.00M | New |
| Selling, general and administrative expenses | 2026 | $234.00M | Raised |
| Medical Marginnon-GAAP | Year Ended December 31, 2026 | $300.00M to $350.00M | New |
| Medicare Advantage Members | Quarter Ended March 31, 2026 | 431,000 to 441,000 | New |
| ACO Model Members | Quarter Ended March 31, 2026 | 105,000 to 110,000 | Lowered |
| Total Members Live on Platform | Quarter Ended March 31, 2026 | 536,000 to 551,000 | Raised |
| Avg. Medicare Advantage Members | Quarter Ended March 31, 2026 | 430,000 to 440,000 | Lowered |
| Geography Entry Costs | Quarter Ended March 31, 2026 | $3.00M | New |
| Medical Marginnon-GAAP | Quarter Ended March 31, 2026 | $115.00M to $130.00M | New |
| Total Revenues | Year Ended December 31, 2026 | $5.41B to $5.58B | New |
| Total Revenues | Quarter Ended March 31, 2026 | $1.35B to $1.39B | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements agilon health filed with the SEC
agilon health Reports Second Quarter 2026 Results
Results of operations · EX-99.1 to Form 8-K
agilon health Reports First Quarter 2026 Results
Results of operations · EX-99.1 to Form 8-K
agilon health Appoints Tim O’Rourke as Chief Executive Officer
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
agilon health Announces Reverse Stock Split
Shareholder vote results · Other events · EX-99.1 to Form 8-K
agilon health Reports Fourth Quarter and Full Year Fiscal 2025 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
4Q and YE 2025 Earnings Presentation February 2026 Copyright © 2025 agilon health. Confidential internal document containing proprietary information. Do not distribute.
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
agilon Announces Receipt of Notice of Non-Compliance with the NYSE Continued Listing Standards
Listing notice · Regulation FD disclosure · EX-99.1 to Form 8-K
agilon health Reports Third Quarter 2025 Results and Re-Establishes Full Year Outlook
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
3Q Earnings Presentation November 2025 Copyright © 2025 agilon health. Confidential internal document containing proprietary information. Do not distribute.
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
agilon health Reports Second Quarter 2025 Results
Results of operations · Executive or director change · Charter or bylaw amendment · Regulation FD disclosure · EX-99.1 to Form 8-K
agilon health Announces Leadership Transition
Results of operations · Executive or director change · Charter or bylaw amendment · Regulation FD disclosure · EX-99.2 to Form 8-K
2Q Earnings Presentation August 2025 Copyright © 2025 agilon health. Confidential internal document containing proprietary information. Do not distribute.
Results of operations · Executive or director change · Charter or bylaw amendment · Regulation FD disclosure · EX-99.3 to Form 8-K
agilon health Reports First Quarter 2025 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
5.6.2025 First Quarter 2025 Earnings Results Copyright © 2025 agilon health. Confidential internal document containing proprietary information. Do not distribute.
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
agilon health Reports Fourth Quarter and Full Year Fiscal 2024 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
February 25, 2025 Fourth Quarter 2024 Earnings Results Copyright © 2024 agilon health
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
November 19, 2024 Wolfe Investor Presentation Copyright © 2024 agilon health
Regulation FD disclosure · EX-99.1 to Form 8-K
agilon health Reports Third Quarter 2024 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
November 7, 2024 Third Quarter 2024 Earnings Results Copyright © 2024 agilon health
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
agilon health Reports Second Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K
agilon health Names Jeff Schwaneke New Chief Financial Officer
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
agilon health Reports First Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K
agilon health Reports Fourth Quarter 2023 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
4Q Earnings Presentation February 2024 Copyright © 2023 agilon health. Confidential internal document containing proprietary information. Do not distribute.
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
agilon health Announces Tim Bensley to Retire as CFO
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
agilon health Provides 2023 Guidance Update, Initial 2024 View
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Guidance Update January 2024 Copyright © 2023 agilon health. Confidential internal document containing proprietary information. Do not distribute.
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Wolfe Healthcare Conference November 2023 Copyright © 2023 agilon health. Confidential internal document containing proprietary information. Do not distribute.
Regulation FD disclosure · EX-99.1 to Form 8-K
agilon health Reports Third Quarter 2023 Results
Results of operations · EX-99.1 to Form 8-K
Supplemental Financial Information (unaudited) 11.2.2023
Results of operations · EX-99.2 to Form 8-K
agilon health Reports Second Quarter 2023 Results
Results of operations · EX-99.1 to Form 8-K
Names Silvana Battaglia to Board of Directors
Executive or director change · Other events · EX-99.1 to Form 8-K
agilon health Reports First Quarter 2023 Results
Results of operations · EX-99 to Form 8-K
agilon health Reports Fourth Quarter and Fiscal Year 2022 Results
Results of operations · EX-99 to Form 8-K
agilon health Reports Third Quarter 2022 Results
Results of operations · EX-99.1 to Form 8-K
agilon health Reports Second Quarter 2022 Results
Results of operations · EX-99.1 to Form 8-K
agilon health Reports First Quarter 2022 Results
Results of operations · EX-99.1 to Form 8-K
agilon health Reports Fourth Quarter and Fiscal Year 2021 Results
Results of operations · EX-99.1 to Form 8-K
agilon health Reports Third Quarter 2021 Results
Results of operations · EX-99.1 to Form 8-K